Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1088 | 986 | 1153 | 1180 | 1618 | 2903 |
Fund Return | 8.83% | -1.4% | 15.31% | 5.67% | 10.11% | 11.25% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Glbl Eq Cl Sr Adv | 7.26B | 7.71 | 4.39 | 9.76 | ||
Manulife Glbl Eq Cl Sr F | 7.26B | 8.81 | 5.68 | 11.11 | ||
Manulife Glbl Eq Cl Sr FT6 | 7.26B | 8.82 | 5.69 | 11.12 | ||
Manulife Glbl Eq Cl Sr T6 | 7.26B | 7.71 | 4.39 | 9.74 | ||
Manulife Div incm Fd Sr Adv | 7.02B | 13.25 | 1.18 | 8.91 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 14.31B | 43.16 | 12.27 | - | ||
Mawer Global Equity | 13.94B | 8.62 | 5.37 | 10.93 | ||
Capital Group Glbal Equity Fd F CAD | 13.86B | 22.86 | 3.88 | 11.66 | ||
Capital Group Glbal Equity Fd A CAD | 13.86B | 21.74 | 2.74 | 10.43 | ||
Capital Group Glbal Equity Fd D CAD | 13.86B | 22.55 | 3.53 | 11.18 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Publicis Groupe | FR0000130577 | 5.25 | 102.50 | +1.69% | |
Marsh McLennan | US5717481023 | 4.94 | 225.73 | +0.25% | |
Microsoft | US5949181045 | 4.20 | 425.20 | +0.51% | |
UnitedHealth | US91324P1021 | 4.15 | 605.87 | -1.43% | |
Alimentation Couche Tard | CA01626P1484 | 3.75 | 78.73 | +1.73% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review